Pre-market · Regular session opens 9:30 AM ET
Last update: Sep 8, 2026, 6:08 PM ET
Scholar Rock Holding Corporation
$57.42 3.78% today
Pre-market

Why Scholar Rock Holding Corporation (SRRK) stock moved

Updated Sep 9, 2026

Scholar Rock Holding Corporation (SRRK) shares rose 3.8% to $57.42 as of September 9, 2026, a moderate gain from the prior close of $55.33. BestStocks flagged the session as a major change for SRRK. The move is tied to price move up. Below, we break down what changed for SRRK, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

SRRK climbed 3.8% to $57.42

SRRK rose 3.8% in its latest session, moving from $55.33 to $57.42.

Material / EarningsLow confidence
Rel. volume
1.3×
Normal
Vs peers
No comparable peers
Market cap
$6.9B
NASDAQ Global Select
Analyst target
$64
+12.2% vs price
Price chart
Aug 10 – Sep 9
EVEEEE$52$56$60Aug 10Aug 17Aug 25Sep 1Sep 9
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Scholar Rock Holding Corporation investors

For Scholar Rock Holding Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Positive 3.8% session move. Weighing against that: Scholar Rock Holding Corporation (SRRK) moved -5.07% from $50.88 to $48.30 on July 22, 2026; Scholar Rock Holding Corporation (SRRK) moved -4.16% from $52.86 to $50.66 on 2026-07-20. Wall Street's consensus price target sits at $64.40, implying +12.2% upside from $57.42. BestStocks rates the overall signal quality low (48/100). With earnings roughly 65 days out, the next report is the most likely near-term test of the move.

SRRK price reaction

SRRK last traded at $57.42, up $2.09 (+3.78%) from the previous close of $55.33. The session traded on 1.3× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $51.89 and $60.04, and it currently sits about 68% of the way up that band.

Bullish and bearish analyst opinions on Scholar Rock Holding Corporation (SRRK)

The consensus analyst price target on Scholar Rock Holding Corporation (SRRK) is $64.40, 12.2% above the recent $57.42. Over the past 90 days analysts logged 0 upgrades, 6 maintains, and 0 downgrades. Here is how the bullish and bearish cases on SRRK line up.

The bullish case

  • Wall Street's consensus price target of $64.40 implies +12.2% upside from $57.42.
  • The Street's most bullish target is $76.00 (+32.4%).
  • Material positive event.
  • Positive 3.8% session move.
  • SRRK moved +4.99% from its $50.14 open to a $52.64 close on 2026-08-06.

The bearish case

  • The most bearish analyst target is $55.00 (-4.2%).
  • Scholar Rock Holding Corporation (SRRK) moved -5.07% from $50.88 to $48.30 on July 22, 2026.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Sep 9, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $64+12.2%
= 6 maintains
HC Wainwright & Co. maintained Buy · 2026-09-08
SEC filings watch
8-K2026-08-06
Material event — review for impact
high
8-K2026-08-06
Material event — review for impact
high
10-Q2026-08-06
Quarterly financial results
medium
8-K2026-06-05
Material event — review for impact
high
Peer context
SRRK+3.8%

Previous notable changes for SRRK

Valuation2026-08-26+3.1%via nz.finance.yahoo.com
Scholar Rock rose 4.52% to $60.88 following positive regulatory updates on its spinal muscular atrophy drug apitegromab. The company announced it removed the Novo Nordisk-owned Catalent Indiana facility from its FDA biologics license application and shifted to an alternate fill-finish facility, while reiterating it expects FDA approval by the September 30 PDUFA date; management added that commercial vials are already produced for immediate launch. Wedbush and JP Morgan recently raised price targets to $63–$64 (Yahoo Finance). Volume trading at 3.01x the historical average at this point in the session.
Material / Earnings2026-08-24+3.0%
Scholar Rock Holding Corporation (SRRK) moved +2.46% from $56.80 to $58.20 on 2026-08-24. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical: SRRK reached a new 30-day high.
Material / Earnings2026-08-18+5.1%
Scholar Rock Holding Corporation (SRRK) moved +5.41% from $51.91 to $54.72 on August 18, 2026, building on recent positive momentum from the FDA's acceptance of its resubmitted application for apitegromab, its spinal muscular atrophy drug candidate, and a bullish price target upgrade from JPMorgan to $63 from $56.
Material / Earnings2026-08-13-1.4%
Scholar Rock Holding Corporation (SRRK) moved -3.25% from $54.84 to $53.06 on 2026-08-13. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Upcoming catalysts & outlook
Next earnings
2026-11-13 (est.)
in 65 days
Earnings Release
2026-11-13
High impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
High
from change events

Frequently asked questions about SRRK

Why did Scholar Rock Holding Corporation (SRRK) stock move?

SRRK rose 3.8% to $57.42. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did SRRK stock rise?

SRRK gained 3.78% ($2.09) versus the prior close of $55.33, last trading at $57.42 on 1.3× average volume.

When is Scholar Rock Holding Corporation's next earnings date?

SRRK's next earnings report is estimated for 2026-11-13 — about 65 days away.

What is the analyst price target for SRRK?

The consensus analyst price target for SRRK is $64.40, about 12.2% above the current $57.42. Over the past 90 days, analysts recorded 0 upgrades, 6 maintains, and 0 downgrades.

How BestStocks tracks SRRK

This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for SRRK, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 9, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.